User login

We offer our registered users tailored information, free online courses and exclusive content.

You have an old EXCEMED account ...

Our platform has been renewed. All users registered at any of the old websites are kindly requested to reset their password. Why is this?

... or you lost your password?

Search results

  1. Scientific Highlights: 2015 Asia Pacific conference on cardiometabolic diseases management

    ... Treatment with renin–angiotensin–aldosterone system (RAAS) blockers are effective in reducing development of hypertension, and also ... after myocardial infarction (MI) and in angina, in which RAAS blockade (with angiotensin-converting enzyme inhibitors [ACEIs] or ...

  2. Complex management of comorbid hypertension, diabetes and thyroid disorders

    ... events Renin–angiotensin–aldosterone system ( RAAS ) blockers may reduce the development of hypertension RAAS blockers may also benefit normotensive patients with diabetes, by ...

  3. Sympathetic activity and hypertension

    ... and peripheral level, from baroreflex modulation to the RAAS system activation. The different methods to assess the activation of ...

  4. Heart rate reduction as a goal in hypertension

    ... activation of the renin-angiotensin-aldosterone system ( RAAS ) and lower levels of plasma renin activity and will respond better to ... patients should respond better to drugs which inhibit the RAAS such as angiotensin converting enzyme (ACE) inhibitors, angiotensin II ...

  5. Highlights from the 21st Annual Scientific Meeting of the Egyptian Hypertension Society

    ... dose adjustment. Renin-angiotensin-aldosterone system (RAAS) inhibitors are the group of hypertensive medications most effective in ... Although all groups of hypertension drugs may be used, RAAS inhibitors and beta-blockers are particularly useful. In his second ...

  6. 2013 Asia–Pacific Cardiology Symposium “From hypertension to heart failure – Interruption of the cardiovascular continuum”

    ... Awwad (Egypt) 11.15 Renin-angiotensin-aldosterone system (RAAS) inhibitors for mortality reduction in hypertension: a recent metaanalysis ...